Cargando…
Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
BACKGROUND: Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease. Great efforts have been recently made to treat AD using mesenchymal stem cells (MSCs), which have immunomodulatory functions. However, the immunomodulatory effects of MSCs need to be enhanced for clinical applic...
Autores principales: | Park, Arum, Park, Hyojung, Yoon, Jisun, Kang, Dayeon, Kang, Myoung-Hee, Park, Y-Y, Suh, Nayoung, Yu, Jinho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387524/ https://www.ncbi.nlm.nih.gov/pubmed/30795812 http://dx.doi.org/10.1186/s13287-019-1164-6 |
Ejemplares similares
-
Innate Type 2 Response to Aspergillus fumigatus in a Murine Model of Atopic Dermatitis–like Skin Inflammation
por: Park, Arum, et al.
Publicado: (2021) -
Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses
por: Song, Ji-young, et al.
Publicado: (2019) -
Toll-like receptors: their roles in pathomechanisms of atopic dermatitis
por: Tamagawa-Mineoka, Risa
Publicado: (2023) -
In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients
por: Well, Serge, et al.
Publicado: (1993) -
The Wound Healing Peptide, AES16-2M, Ameliorates Atopic Dermatitis In Vivo
por: Kim, Myun Soo, et al.
Publicado: (2021)